SCHEMBL19234012

SCHEMBL19234012

N[C@@H]1CN[C@H](C(=O)NCc2ccccc2)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 2/20 0.57
▸ DPP4 P27487 1/20 0.54
▸ HPGD P15428 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ DPP8 Q6V1X1 1/20 0.48
▸ DPP9 Q86TI2 1/20 0.48
▸ DPP7 Q9UHL4 1/20 0.48
▸ HTR2C P28335 1/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ CACNA1G O43497 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ ANPEP P15144 2/20 0.46
▸ LNPEP Q9UIQ6 2/20 0.46
▸ KDM1A O60341 1/20 0.46
▸ RCOR1 Q9UKL0 1/20 0.46
▸ MAOA P21397 1/20 0.46
▸ MASP2 O00187 2/20 0.45
▸ F2 P00734 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19234280 0.84 CFD (0.46) MC4RDPP4DPP8DPP9DPP7
SCHEMBL1162854 0.84 MC4R (0.59) MC4RDPP4HPGDUSP2ALDH1A1
SCHEMBL18576456 0.83 CTSC (0.59) MC4RDPP4HPGDUSP2ALDH1A1
SCHEMBL18556183 0.83 CTSC (0.59) MC4RDPP4HPGDUSP2ALDH1A1
SCHEMBL7067405 0.83 CTSC (0.59) MC4RDPP4HPGDUSP2ALDH1A1
SCHEMBL25111799 0.83 CTSC (0.59) MC4RDPP4HPGDUSP2ALDH1A1
SCHEMBL19233889 0.82 P2RX7 (0.48) MC4RALDH1A1DPP8DPP9DPP7
Hydrochloric Acid SCHEMBL18546507 0.82 CTSC (0.58) MC4RDPP4HPGDUSP2ALDH1A1
Hydrochloric Acid SCHEMBL18554365 0.82 CTSC (0.58) MC4RDPP4HPGDUSP2ALDH1A1
SCHEMBL19234311 0.81 GID4 (0.44) HPGDDPP8DPP9DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2661433-B1 INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) NOVARTIS AG (CH) 2017-08-16 — — EP disclosed
Send feedback